INTRODUCTION
Astrogliosis is a classic hallmark of trauma and disease of the central nervous system (5, 6) . It is believed that the role of gliosis in the adult is to wall off the area of injury which, in turn, prevents local regeneration of neuronal processes (25) . Recently, a molecular component associated with the extracellular matrix of astroglial scars following trauma has been shown to be a c~ondroitin-6-sulfate-containing proteoglycan (21) . In lnVD; this proteoglycan, found in the adult cortex, coloalizes with intensely GFAP-positive astrocytes in and llll:rnediately adjacent to induced scars, but not with other GF AP-positive astrocytes distant from the injury site (21) . Neurons fail to elaborate axons in vitro on the surface of scars removed intact from adults, unless the glycosaminoglycan chains are digested with chondroitinase, suggesting that chondroitin sulfate-containing proteoglycan deposition may be involved in limiting the growth of regenerating axons in the CNS (22) . This idea is supported by the finding that certain proteoglycans found during development have been shown to be regulatory to axonal outgrowth. For instance a chondroitin sulfate/keratan sulfate-containing proteoglycan, located on astrocytes in boundary regions of the developing embryo, limits axon elongation in vitro (7, 32 ) and a chondroitinase-sensitive proteoglycan regulates the patterning ofaxons in the retina (4) .
Apart from trauma, gliosis may be a normal consequence of senescence in the brain and especially in neurodegenerative diseases, where there is an increase in reactive glia in response to failing CNS mechanisms (9, 12, 18, 26) . Accordingly, astrogliosis could playa fundamental role in the development of pathological lesions in Alzheimer's disease (AD) (10) . In the AD brain, reactive astrocytes are found in high abundance around molecularly heterogenous cores of IJ-amyloid found within senile plaques (9, 12, 13, 23) . Also, the presence of various sulfated proteoglycans in association with amyloid fibrils (29, 30, 31, 37) suggests that reactive gliosis could contribute specified extracellular matrix components to the forming IJ-amyloid aggregate. Indeed, the plaque-related glial interactions may be triggered by the deposition of IJ-amyloid (19) and might represent an attempt to wall off the IJ-amyloid core.
Neither the source of plaque-associated proteoglycans nor the effect these molecules have on neuronal survival or neurite dystrophy in AD are known. In this report, we have investigated the hypothesis that neurite retraction or neuronal death in the AD brain is a consequence of secondary cellular reactions in the form of a functionally reactive gliosis, triggered by insoluble 1-40 and 25-35 peptide fragments of IJ-amyloid variously re- gliosis, we propose, leads to the deposition of inhibitory molecules which are severely adverse to neuronal process survival.
METHODS

In Vitro Spot Assay
For preparation of substrates for the spot assays, 0.5-1 ,ul of a 2 roM solution of (J-amyloid peptides (1-40 and 25-35 amino acids were obtained from Bachem California Inc., scrambled 25-35 and scrambled 1-40 kindly donated by Gliatech, Inc.) were allowed to air-dry under sterile conditions onto nitrocellulose-coated 35-mm petri dishes or Flaskette chambers (for time-lapse videomicroscopy). This produced peptide spots in the range of 0.7-1.2 mm in diameter which visibly adhered to the surface of the dish and persisted for the duration of the experiments (confirmed by ponceau S staining of peptide). Prior to seeding cells, substrates were overlayed with a 5 ,ug/ml solution of laminin in calcium-magnesium-free Hanks' balanced salt solution (CMF).
Culture of Cortical Neurons
Cortical neurons were obtained from Embryonic Day 16 rat embryos. Following removal of fetuses from the mother, cerebral cortices were removed into CMF and cut into small pieces and trypsinized for 10 min at 37°C. Following the addition of DMEM-F12 supplemented with 10% FCS, cells were resuspended to a determined cell density and plated onto prepared peptide spot substrates. For seeding onto conditioned spots, glial cells were first removed from the dishes after 2-14 days by extensive washes with sterile distilled water, after which cortical neurons were seeded as above.
Filter Implant Assay
For testing the in vivo response to (J-amyloid peptides, pieces of Millipore filter either impregnated with (Jamyloid peptide (n = 10) or saline (control; n = 10) were implanted into the cerebral cortex of neonatal rats. Briefly, both groups of PO animals were anesthetized on ice. An incision was made on the dorsal surface of the head and the skin was retracted. The skull was cleaned of the periosteum and a small rectangular opening made through the skull. Next, a 2 X 2-mm piece of sterile nitrocellulose filter (Millipore Corp.) was implanted into the cerebral cortex, and the incision was closed. After 30 days animals were anesthetized with chloral hydrate and perfused with 4 % paraformaldehyde. The brains were postfixed for 4 h in the same fixative and then cryoprotected with sucrose prior to cryostat sectioning and staining for the presence of chondroitin sulfate-containing proteoglycan. Sections from the brains of these animals were also stained for the presence of (J-amyloid (antibody kindly provided by 'G. Perry) showed that (J-amyloid does not noticeably dissi and over the 30-day For seeding onto peptides in the spot assays, glial cells were removed from these cultures following a similar trypsinization protocol, resupended to a determined concentration, and plated onto prepared peptide substrates (as described above).
Timelapse Video microscopy
Once seeded with glia or neurons, time-lapse videomicroscopy was performed on selected cultures using an inverted Zeiss microscope at various magnifications. Time-lapsed cultures were maintained at 37°C for up to 3 days with a thermostatically controlled heated air blower and filmed using a Hamamatsu CCD camera. Films were made of cells on and off the (J-amyloid spots ( after differing times postseeding (from Time 0 to 14 days postseeding). Under either Nomarski or phase-I contrast optics, images were taken every 100-360 s us-\ ing a MetelTek shutter control system operated by an j Image 1 system. Digitized images were averaged, con-\ trast-enhanced where required, and stored on a Pan-) sonic LF 7010 optical disc recorder. Selected videoprints ) were made from stored images with a Sony 500-W video printer. )
Immunohistochemistry
For immunocytochemistry, cultures were briefly rinsed in PBS and fixed for 12 h at 4°C with 4% formal
saline. For the filter implants, brains were perfused with { the same fix and cryosectioned after which sections were treated the same as cultures. Fixed cultures and i sections were washed extensively with PBS and blocked for 2 h with 0.1 % BSA/4% NGS in PBS. Cultures and i sections were then exposed to a mixture of antibodies:
GF AP (Accurate Chemical, specific for glial acidic fi-{ brillar protein) and CS-56, (ICN ImmunoBiologicals, which recognizes chondroitin 6-sulfate-containing pro-( teoglycans), optimally diluted in staining buffer (0.01 % BSA/O.4% NGS in PBS containing 0.01% Tween 20). After 1 h, the primary cocktail was washed away with multiple changes of staining buffer and then exposed to an optimally diluted mixture of biotinylated goat antimouse IgM and fluorescein-conjugated goat anti-rabbit IgG in staining buffer. After incubation with secondary cocktail, cultures were washed as before and incubated with strepavidin-conjugated Texas Red (Amersham).
Cultures were rinsed and coverslipped in Citifluor (Citifluor Ltd.) and viewed on a Leitz Orthoplan 2 microscope fitted for phase-contrast, DIC, and fluorescence optics. Control staining was carried out as follows. Cultures which had either or both primaries omitted in the above protocol did not show any significant staining. Likewise, peptide spots exposed to culture medium alone for 14 days in the absence of cells stained negative with CS-56. The presence of chondroitin sulfate proteoglycan in our cultures and filter implants was confirmed with another monoclonal antibody, 3B3, which recognizes the sugar stubs of chondroitin-6-sulfate glycosaminoglycan side chains near the protein core of the proteoglycan after chondroitinase digestion. For immunocytochemistry of AD tissue, human hippocampus and frontal cortex were obtained postmortem, fixed in Methacarn (MeOH, 60%; acetic acid, 10%; chloroform, 30%), and embedded in paraffin wax. 
A.dherence of Cortical Neurons to (3-Amyloid
Behavior of Cortical Glia on {3-Amyloid Substrates
When glial cells were seeded onto the 25-35, 1-40, scrambled 25-35, or scrambled 1-40 amino acid peptides of the {3-amyloid molecule, they initially attached and spread on all of the peptide surfaces showing no preference for the peptide spots over the surrounding laminin substrate. However, time-lapse videomicroscopy of the glial cultures on each of the nonscrambled amyloid components showed that glial cells exhibit different behaviors on the peptide substrates compared to cells off the peptide spots. Within a matter of hours, cells resident on the peptide spots underwent a profound change in morphology by producing many elongated processes. In addition, the motility of cells on the peptides dramatically increased relative to those seeded away from the spot. During their time on the 25-35 and 1-40 peptides some cells showed alternating periods of motility and quiescence. However, even during the stationary phase, these cells showed a pronounced ruffling of the cell surface not shown by cells off the spots. Glial cells traversed the border on and off the peptide sub- [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] peptide spots, cells remain resident for many days but gradually the density on these peptides declines at comparable rates (n = 46). Cells on the scrambled 1-40 and [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] peptide spots remain at similar densities as on the surrounding substrate (n = 12) .. strate freely, indicating that the border of the peptide was not a physical barrier to cell movements and that the peptides were not inherently nonadhesive or repulsive to glial cells. Glial cells do not exhibit increased motility or the same changes in morphology in preparations of scrambled 25-35 or scrambled 1-40 peptides. With time, the density of glial cells on the 1-40 or 25-35 peptide substrate decreases relative to the cell density off the spot (Fig. 2 ). This appears to occur by cells on the peptide spots eventually wandering off the peptides without returning. Cells left on these peptides sometimes form aggregates on the peptide surface which is not seen by cells off the spots. Thus, time-lapse videomicroscopy revealed glial cells to have altered behavior, in terms of cell movements and morphologies, on the 1-40 and 25-35 peptides. This seemingly "reactive" behavior on the 1-40 and 25-35 ,a-amyloid peptide spots led us to examine the possibility that glial cells had initiated the deposition of gliotic scar components while in contact with the ,a-amyloid peptides.
Cortical Glia Condition ,a-Amyloid Substrates by ECM Deposition
After 14 days exposure of the 25-35 and 1-40 peptide spots, glial cells were replaced with cortical neurons. Unlike cortical neurons seeded directly onto unconditioned 25-35 and 1-40 peptides, cells now failed to show an adhesive preference for the preconditioned spot, with far fewer cells adhering to the spot than the surrounding laminin substrate (Figs. 1 and 3B ). Control spots left in culture for the same time period but without exposure to glial cells still permitted preferential neuron adhesion. This indicated that the surface of the peptide spot exposed to glia had become an unfavorable substrate to the attachment and growth of neurons as a consequence of glial reactivity.
We therefore tested glial-conditioned 25-35 and 1-40 peptide spots for the presence of glycosaminoglycanbearing proteoglycans, an indicator of functionally reactive gliotic scar formation after trauma (21) . After 5 days in culture, chondroitin sulfate-containing proteoglycan deposition could be seen at points of cell contact with the peptide (Fig. 4) . The deposition of chondroitin sulfate proteoglycan on the peptide spots increased with longer exposures to glial cells (Fig. 5) . Over the surface of the peptide spots irregularly shaped, cell~sized blotches of chondroitin sulfate-containing proteoglycan were found (Fig. 5A ) and the complete circumferences of the 25-35 and 1-40 peptides were eventually "walled off" by high amounts of chondroitin sulfate deposition after 14 days in culture (Figs. 5B and 5C ). Chondroitin sulfate-containing proteoglycan was not deposited on scrambled 1-40 and scrambled 25-35 peptides over com' parable time periods. Thus, we propose that glial cells become reactive when they are in contact with immobilized 1-40 and 25-35 peptides of the ,a-amyloid molecule and that this reactivity is manifested by the local deposition of enhanced amounts of chondroitin sulfate-bearing proteoglycan. Since analysis of time-lapse films revealed no apparent difference in the rates of mitosis between cells on the peptide spots and those off tlie spots, this form of reactive gliosis is associated with a large increase in cell motility but without any discernible increase in cell numbers. 
In Vivo Response to Immobilized fJ-Amyloid
We then examined whether chondroitin sulfate proteo glycan is also deposited in excess in response to the presence of fJ-amyloid in intact tissue. Neonatal rats, which do not form chondroitin sulfate-containing scars after lesions to the cortex (21), were implanted with nitrocellulose filters impregnated with 1-40 fJ-amyloid and allowed to survive 30 days (21, 22) . Approximately the same number of GFAP-positive processes and cells were seen infiltrating control and fJ-amyloid implants (Figs. 6A and 6C) . However, fJ-amyloid filters contained significant amounts of chondroitin sulfate-containing proteoglycan while comparable control filters revealed little or no staining (Figs. 6B and 6D) . Thus, glial cells in intact living tissue react to the presence of fJ-amyloid by producing chondroitin sulfate-bearing proteoglycan in a manner similar to glia confronted with fJ-amyloid in vitro.
Chondroitin Sulfate Proteoglycan in Human AD Tissue
The finding that fJ-amyloid peptides induce enhanced deposition of chondroitin sulfate proteoglycan in the cortex ofliving rats, even when removed from the direct effects of trauma, prompted us to search in human tissue for the association of chondroitin sulfate proteoglycan with senile plaques in AD patients. Using antibodies against various glycosaminoglycan portions of chondroitin sulfate proteoglycan, we found greatly enhanced amounts of chondroitin sulfate proteoglycan at the periphery of senile plaque cores (Fig. 7) . Bearing some similarity to our in vivo filter implants, the proteoglycan was found to be associated with GF AP-positive astrocytes in the near vicinity of senile plaques (Fig. 7C) . Importantly, this distribution of chondroitin sulfate proteo glycan corresponds closely to the region around senile plaques which has both a decline in neuritic density and an increase ofaxons exhibiting AD-associated cytoskeletal damage (2) . Therefore, it appears likely that the same events of reactive gliosis and deposition of chondroitin sulfate proteoglycan are taking place in the AD brain as in our in vitro and in vivo models.
DISCUSSION
Our study has focused on the possibility that neuritic retraction and/or neuronal dystrophy associated with Alzheimer-like plaques is not simply a consequence of ,B-AMYLOID INDUCES GLIOSIS 297 direct neurotoxicity by ,B-amyloid (as it has been suggested in solution (15, 20, (34) (35) (36) or as insoluble peptide aggregates (8, 24) , but also of secondary glial cell reactions to the insoluble molecule. The ,B-amyloid peptides I were bound to a substrate in our experimental model systems and, therefore, it may be argued that this presentation of ,B-amyloid peptides to cortical cells more closely mimics the situation of AD plaques in vivo where p-amyloid is present in fibrillar form. We have shown j for the first time that ,B-am~loid peptide ~s able to ~nduce I glial cells to become functlOnally reactIve both m culture and in the intact animal in that they specifically deposit enhanced quantities of chondroitin-6-sulfate proteoglycan, a known inhibitor of neuronal regeneration found in glial scars. We propose that the chondroitin sulfate proteoglycan present around senile plaques of patients with AD, perhaps along with other proteoglycans previously described in association with senile plaques (8, 24, (29) (30) (31) , may be a link in the chain of events that ultimately leads to neuronal dystrophy and possibly neuronal loss.
The distinguishing feature by which ,B-amyloid is able to act as an inducer of reactive gliosis is an especially important but perplexing problem in light of the recent observation that the ubiquitiously distributed (33) amyloid precursor protein (APP), from which ,B-amyloid is abherrantly cleaved, may itself be a chondroitin sulfatebearing proteoglycan core protein (27) . If this were the case, then deposition of APP by a variety of injured cells of which there is some evidence (14, 28) could be a global initiator of scar formation in the CNS if the molecule were fragmented and modified extracellularly (by microglia or reactive astrocytes (1)), perhaps in response to the abnormal presence of a proteoglycan core protein. In this way, ,B-amyloid could be considered to be a molecular trigger of gliosis among other candidate molecules such as cytokines and growth factors (11, 17) . It remains to be determined whether gliosis triggered by ~-amyloid results in the deposition of a variety of scarassociated molecules including different species of proteoglycans along with other extracellular matrix moleCUles such as tenascin (21) . In the AD brain, such a process may explain why plaque-associated axonal damage extends out and away from the dense ,B-amyloid core (2) into the reactive astroglial areas and why characteristic neuritic dystrophy occurs specifically in response to ,BamYloid deposition (3). Furthermore, our findings that ~-amyloid supports neuronal attachment, perhaps via Some modification of laminin (16) , unless conditioned ?yglia suggests that the extracellular matrix surroundlUg plaques could curtail neurite regeneration in the AD .brain. Given the potent inhibitory nature of certain proteoglycans to neuronal cells, especially the inhibition by tyPes of chondroitin-6-sulfate proteoglycan (32), this Would suggest that glia can play important roles not Only in the creation of axonal boundaries during normal development, but also in the pathology of CNS lesions and neurodegenerative disorders such as Alzheimer's disease.
